Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition
March 18, 2022
Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition
kdunleavy
Fri, 03/18/2022 – 18:13
Source link